1,3,2-Dioxaborinane-4-acetic acid, 4-carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-
CAS:1201902-80-8
Formula:
C20H23BCl2N2O9
Color and Shape:
Solid
Molecular weight:
517.1216
Ref: AN-AG000QJT
Undefined size | To inquire |
Estimated delivery in United States, on Monday 13 May 2024
MLN9708
CAS:1201902-80-8
MLN2238 suppresses the chymotrypsin-like proteolytic (β5) site of the 20S proteasome(Ki50=0.93 nM, IC50=3.4 nM/). The …
Formula:
C20H23BCl2N2O9
Purity:
98.79%
Color and Shape:
Solid
Molecular weight:
517.12
Ref: TM-T2016
5mg | 50.00 € | |
10mg | 66.00 € | |
25mg | 94.00 € | |
50mg | 129.00 € | |
100mg | 211.00 € | |
200mg | 314.00 € | |
500mg | 523.00 € | |
1ml*10 (DMSO) | 52.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
MLN-9708
Controlled ProductCAS:1201902-80-8
Applications MLN-9708 is a novel proteasome inhibitor. References Kupperman, Erik., et al.: Cancer Res., 70, …
Formula:
C20H23BCl2N2O9
Color and Shape:
White to Off-White Solid
Molecular weight:
517.12
Ref: TR-M425158
5mg | 101.00 € | |
10mg | 171.00 € | |
50mg | 315.00 € |
Estimated delivery in United States, on Friday 21 Jun 2024
Ixazomib Citrate (MLN9708)
CAS:1201902-80-8
Ixazomib Citrate (MLN9708) is a proteasome inhibitor that belongs to the class of investigational agents. …
Formula:
C20H23BCl2N2O9
Purity:
Min. 95%
Molecular weight:
517.12 g/mol
Ref: 3D-BYB90280
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Tuesday 25 Jun 2024